Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation‐wide Case‐Crossover Study
Open Access
- 30 January 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 4 (2)
Abstract
Background: Antipsychotics have been linked to prolongation of the QT interval. However, little is known about the risk of ventricular arrhythmia (VA) and/or sudden cardiac death (SCD) associated with individual antipsychotic drug use. This study was designed to investigate the association between specific antipsychotic drugs and the risk of VA and/or SCD . Methods and Results: We conducted a case‐crossover study using a nation‐wide population‐based sample obtained from Taiwan's National Health Insurance Research Database. A total of 17 718 patients with incident VA and/or SCD were enrolled. Conditional logistic regression models were applied to examine the effects of antipsychotic drug use on the risk of VA / SCD during various case and control time windows of 7, 14, and 28 days. The effect of the potency of a human ether‐à‐go‐go‐related gene ( hERG) potassium channel blockade was also assessed. Antipsychotic drug use was associated with a 1.53‐fold increased risk of VA and/or SCD. Antipsychotic drugs with increased risk included clothiapine, haloperidol, prochlorperazine, thioridazine, olanzapine, quetiapine, risperidone, and sulpiride. The association was significantly higher among those with short‐term use. Antipsychotics with a high potency of the hERG potassium channel blockade had the highest risk of VA and/or SCD. Conclusion: Use of antipsychotic drugs is associated with an increased risk of VA and/or SCD. Careful evaluations of the risks and benefits of antipsychotic treatment are highly recommended.Keywords
This publication has 32 references indexed in Scilit:
- Risk of Mortality (Including Sudden Cardiac Death) and Major Cardiovascular Events in Atypical and Typical Antipsychotic Users: A Study with the General Practice Research DatabaseCardiovascular Psychiatry and Neurology, 2013
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugsNature Reviews Endocrinology, 2011
- Assessing QT Interval Prolongation and its Associated Risks with AntipsychoticsCNS Drugs, 2011
- Risk of Serious Cardiac Events in Older Adults Using Antipsychotic AgentsThe American Journal of Geriatric Pharmacotherapy, 2011
- Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic MedicationsJournal of Clinical Psychopharmacology, 2007
- Conventional and Atypical Antipsychotics and the Risk of Hospitalization for Ventricular Arrhythmias or Cardiac ArrestArchives of internal medicine (1960), 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Drug induced QT prolongation and torsades de pointesHeart, 2003
- Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden DeathDrugs, 2002
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden DeathAmerican Journal of Psychiatry, 2001